Thrombophilia - Expanded Panel (MTHFR + F2 + F5 + SERPINE-1)
Identification of mutations predisposing to thrombosis in the patient's genetic material. The test includes the identification of mutations in the Factor V gene (F5), mutations in the Prothrombin gene (F2), and polymorphisms in the MTHFR gene.
Available in stock
Fast turnaround time
Secure courier delivery
Convenience and comfort of shopping
Fast shipping
Directly from the manufacturer
Secure payments
Blik, Przelewy24
Thrombophilia is defined as a predisposition to developing thrombosis. Thrombosis is a pathological process in which a blood clot forms within a blood vessel. When a clot forms in an artery, it is referred to as arterial thrombosis, and when it forms in a vein, it is called venous thrombosis. The most common sites of venous thrombosis are the veins in the lower limbs and pelvis. Clots forming in the coronary artery can lead to heart attacks. The predisposition to developing thrombosis can be hereditary or acquired.
Causes of Acquired Thrombophilia:
- Antiphospholipid syndrome
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Dermatomyositis
- Infections and inflammatory conditions: ulcerative colitis, Crohn's disease
- Cancer and chemotherapy: leukemia, lymphomas, colorectal cancer, lung cancer
Causes of Hereditary Thrombophilia:
- Mutations in the factor V gene (F5)
- Mutations in the factor II (prothrombin) gene (F2)
- Deficiency of coagulation inhibitors caused by mutations in the genes: antithrombin (SERPINC1 gene mutation), protein C (PROC gene mutation), and protein S (PROS1 gene mutation). Antithrombin (AT), protein C (PC), and protein S (PS) are endogenous inhibitors of the coagulation process
- Polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR)
- Polymorphisms in plasminogen activator inhibitor-1 (PAI1)
Most Common Symptoms of Thrombosis:
- Asymmetrically swollen limbs
- Cyanosis of the feet and lower legs
- Pain while walking
- Pain and redness at the site of swelling
- Dilated blood vessels
- Increased heart rate
- Chest pain
Purpose of the Test:
Identification of mutations in the patient's genetic material that predispose to thrombosis. The test includes identification of mutations in the Factor V gene (F5), Prothrombin gene (F2), and MTHFR gene polymorphism.
These mutations:
- Are the most common cause of hereditary thrombophilia
- Increase the risk of venous and arterial thrombosis, heart attack, stroke
- Are causes of cardiovascular diseases, including thromboembolic complications
In pregnant women:
- Increase the risk of recurrent miscarriages
- May lead to premature placental abruption
- May lead to the development of preeclampsia
- May lead to fetal growth restriction
- May lead to intrauterine fetal death
- May lead to neural tube defects and cleft lip and palate in the fetus
Indications for the Test:
- Symptoms of thromboembolic disease
- Family history
- Past episodes of thrombosis
- Planned surgery involving prolonged immobilization
- Recurrent miscarriages or stillbirths
- Use of hormonal contraception
- Use of hormone replacement therapy
- Thrombocytopenia
- Cancer
- Sedentary lifestyle
- Obesity
Method:
Real-time PCR
High sensitivity of the test – 99%
Sample Material:
EDTA blood
Oral swab